Choice Defines QALYs A US Valuation of the EQ-5D-5L

被引:37
|
作者
Craig, Benjamin M. [1 ]
Rand, Kim [2 ,3 ]
机构
[1] Univ S Florida, Dept Econ, 4202 E Fowler Ave,CMC206A, Tampa, FL 33620 USA
[2] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[3] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
基金
美国国家卫生研究院;
关键词
quality-adjusted life years; patient preference; choice behavior; health valuation; cost-utility analyses; value of life; quality of life; patient reported outcome measures; TIME TRADE-OFF; SUBJECTIVE HEALTH OUTCOMES; UNITED-STATES; VALUE SET; PREFERENCE RESEARCH; VALUES; TTO; DURATION; ADULTS; MODEL;
D O I
10.1097/MLR.0000000000000912
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The 5-level version of the EQ-5D (EQ-5D-5L) was introduced as an improvement on the original 3-level version (EQ-5D-3L). To date, 6 country-specific value sets have been published for EQ-5D-5L and 9 US value sets have been published for other instruments. Our aims were to (1) produce EQ-5D-5L values on a quality-adjusted life year (QALY) scale from the perspective of US adults and (2) compare them with US EQ-5D-3L values and the other country-specific EQ-5D-5L values. Methods: In 2016, 8222 US respondents from all 50 states and Washington, DC completed an online survey including a discrete choice experiment with 20 paired comparisons. Each comparison asked respondents, "Which do you prefer?" regarding a pair of alternatives described using EQ-5D-5L and lifespan attributes. On the basis of more than 50 choices on each of the 3160 pairs, we estimated EQ-5D-5L values on a QALY scale and compared them with the US EQ-5D-3L values and the other country-specific EQ-5D-5L values. Results: Ranging from -0.287 (55555) to 0.992 (11121) on a QALY scale, the estimated EQ-5D-5L values were similar to the US EQ-5D-3L values. Compared with the US EQ-5D-3L values, the values exhibited greater sensitivity and specificity and higher correlation with the EQ-5D-5L values of other countries, particularly England. Conclusions: Like previous US valuation studies, this study produced nationally representative EQ-5D-5L values on a QALY scale. The results further demonstrate the advantages of the EQ-5D-5L over its 3-level predecessor as a preference-based summary measure of health-related quality of life from the perspective of US adults.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 50 条
  • [1] CHOICE DEFINES QALYS: A US VALUATION OF THE EQ-5D-5L
    Craig, B. M.
    Rand, K.
    [J]. VALUE IN HEALTH, 2018, 21 : S12 - S12
  • [2] Valuation of the EQ-5D-5L in Taiwan
    Lin, Hsiang-Wen
    Li, Chia-Ing
    Lin, Fang-Ju
    Chang, Jen-Yu
    Gau, Churn-Shiouh
    Luo, Nan
    Pickard, A. Simon
    Goni, Juan M. Ramos
    Tang, Chao-Hsiun
    Hsu, Chien-Ning
    [J]. PLOS ONE, 2018, 13 (12):
  • [3] EQ-5D-5L valuation study for Portugal
    Ferreira, Pedro L.
    Antunes, Patricia
    Ferreira, Lara N.
    Pereira, Luis N.
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 87 - 87
  • [4] QALYs for COVID-19: A Comparison of US EQ-5D-5L Value Sets
    Stephen Poteet
    Benjamin M. Craig
    [J]. The Patient - Patient-Centered Outcomes Research, 2021, 14 : 339 - 345
  • [5] The EQ-5D-5L valuation study in Korea
    Seon-Ha Kim
    Jeonghoon Ahn
    Minsu Ock
    Sangjin Shin
    Jooyeon Park
    Nan Luo
    Min-Woo Jo
    [J]. Quality of Life Research, 2016, 25 : 1845 - 1852
  • [6] QALYs for COVID-19: A Comparison of US EQ-5D-5L Value Sets
    Poteet, Stephen
    Craig, Benjamin M.
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2021, 14 (03): : 339 - 345
  • [7] EQ-5D-5L Valuation for the Malaysian Population
    Shafie, Asrul Akmal
    Thakumar, Annushiah Vasan
    Lim, Ching Jou
    Luo, Nan
    Rand-Hendriksen, Kim
    Yusof, Faridah Aryani Md
    [J]. PHARMACOECONOMICS, 2019, 37 (05) : 715 - 725
  • [8] EQ-5D-5L VALUATION STUDY IN TAIWAN
    Lin, H.
    Li, C.
    Lin, F.
    Chang, J.
    Gau, C.
    Luo, N.
    Pickard, A. S.
    Goni, Ramos J. M.
    Tang, C.
    Hsu, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S91 - S91
  • [9] EQ-5D-5L Valuation for the Malaysian Population
    Asrul Akmal Shafie
    Annushiah Vasan Thakumar
    Ching Jou Lim
    Nan Luo
    Kim Rand-Hendriksen
    Faridah Aryani Md Yusof
    [J]. PharmacoEconomics, 2019, 37 : 715 - 725
  • [10] The EQ-5D-5L Valuation study in Thailand
    Pattanaphesaj, Juntana
    Thavorncharoensap, Montarat
    Ramos-Goni, Juan Manuel
    Tongsiri, Sirinart
    Ingsrisawang, Lily
    Teerawattananon, Yot
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (05) : 551 - 558